Clinical Trial Update: Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 study evaluating droxidopa for freezing of gait in Parkinson's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Droxidopa (Droxidopa)

Snippet

Sponsor: Chelsea Therapeutics | Conditions: Gait Disorders, Neurologic | Phase 1, Phase 2 | Status: WITHDRAWN